Literature DB >> 20809773

The influence of early embryo traits on human embryonic stem cell derivation efficiency.

Thomas O'Leary1, Björn Heindryckx, Sylvie Lierman, Margot Van der Jeught, Björn Menten, Dieter Deforce, Ria Cornelissen, Susana Chuva de Sousa Lopes, Petra De Sutter.   

Abstract

Despite its prognostic value in in vitro fertilization, early embryo morphology is not reported on in the derivation of human embryonic stem cell (hESC) lines. Standard hESC derivation does rely on blastocyst development and its efficiency is highly correlated to inner cell mass (ICM) quality. Poor-quality embryos (PQEs) donated for hESC derivation may have a range of cleavage-stage abnormalities that are known to compromise further development. This study was implemented to determine whether specific PQEs traits influence the efficiency of good-quality ICMs to derive new hESC lines. We found that although the types of PQEs investigated were all able to make blastocysts with good-quality ICMs, the ICMs were unequal in their ability to derive hESCs. Good-quality ICMs from embryos with multiple poor-quality traits were unable to generate hESC lines, in contrast to good-quality ICMs from embryos with a single poor-quality trait. In addition, our data suggest a direct correlation between the number of ICM cells present in the blastocyst and its capacity to derive new hESC lines. This study is the first to demonstrate that ICM quality alone is an incomplete indicator of hESC derivation and that application of in vitro fertilization-based early embryo scoring can help predict hESC derivation efficiency. Experiments aiming to quantify, improve upon, or compare hESC derivation efficiency should thus take into consideration early embryo morphology scoring for the comparison of groups with equal developmental competence.

Entities:  

Mesh:

Year:  2010        PMID: 20809773     DOI: 10.1089/scd.2010.0338

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  10 in total

1.  Tracking the progression of the human inner cell mass during embryonic stem cell derivation.

Authors:  Thomas O'Leary; Björn Heindryckx; Sylvie Lierman; David van Bruggen; Jelle J Goeman; Mado Vandewoestyne; Dieter Deforce; Susana M Chuva de Sousa Lopes; Petra De Sutter
Journal:  Nat Biotechnol       Date:  2012-02-26       Impact factor: 54.908

2.  Vitrified blastocysts from Preimplantation Genetic Diagnosis (PGD) as a source for human Embryonic Stem Cell (hESC) derivation.

Authors:  Begoña Aran; Miquel Sole; Ignasi Rodriguez-Pizà; Mònica Parriego; Yolanda Muñoz; Montserrat Boada; Pere N Barri; Juan Carlos Izpisúa; Anna Veiga
Journal:  J Assist Reprod Genet       Date:  2012-06-27       Impact factor: 3.412

3.  Derivation of human embryonic stem cells using a post-inner cell mass intermediate.

Authors:  Thomas O'Leary; Björn Heindryckx; Sylvie Lierman; Margot Van der Jeught; Galbha Duggal; Petra De Sutter; Susana M Chuva de Sousa Lopes
Journal:  Nat Protoc       Date:  2013-01-10       Impact factor: 13.491

4.  Influence of activin A supplementation during human embryonic stem cell derivation on germ cell differentiation potential.

Authors:  Galbha Duggal; Björn Heindryckx; Sharat Warrier; Thomas O'Leary; Margot Van der Jeught; Sylvie Lierman; Liesbeth Vossaert; Tom Deroo; Dieter Deforce; Susana M Chuva de Sousa Lopes; Petra De Sutter
Journal:  Stem Cells Dev       Date:  2013-08-14       Impact factor: 3.272

5.  The combination of inhibitors of FGF/MEK/Erk and GSK3β signaling increases the number of OCT3/4- and NANOG-positive cells in the human inner cell mass, but does not improve stem cell derivation.

Authors:  Margot Van der Jeught; Thomas O'Leary; Sabitri Ghimire; Sylvie Lierman; Galbha Duggal; Karen Versieren; Dieter Deforce; Susana Chuva de Sousa Lopes; Björn Heindryckx; Petra De Sutter
Journal:  Stem Cells Dev       Date:  2012-08-06       Impact factor: 3.272

6.  Application Of Small Molecules Favoring Naïve Pluripotency during Human Embryonic Stem Cell Derivation.

Authors:  Margot Van der Jeught; Jasin Taelman; Galbha Duggal; Sabitri Ghimire; Sylvie Lierman; Susana M Chuva de Sousa Lopes; Dieter Deforce; Tom Deroo; Petra De Sutter; Björn Heindryckx
Journal:  Cell Reprogram       Date:  2015-06       Impact factor: 1.987

7.  Cell lineage specific distribution of H3K27 trimethylation accumulation in an in vitro model for human implantation.

Authors:  Gijs Teklenburg; Charlotte H E Weimar; Bart C J M Fauser; Nick Macklon; Niels Geijsen; Cobi J Heijnen; Susana M Chuva de Sousa Lopes; Ewart W Kuijk
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

8.  Reference loci for RT-qPCR analysis of differentiating human embryonic stem cells.

Authors:  Liesbeth Vossaert; Thomas O'Leary; Christophe Van Neste; Björn Heindryckx; Jo Vandesompele; Petra De Sutter; Dieter Deforce
Journal:  BMC Mol Biol       Date:  2013-09-12       Impact factor: 2.946

9.  High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos.

Authors:  Jinpei Ye; Nicola Bates; Despina Soteriou; Lisa Grady; Clare Edmond; Alex Ross; Alan Kerby; Philip A Lewis; Tope Adeniyi; Ronnie Wright; Kay V Poulton; Marcus Lowe; Susan J Kimber; Daniel R Brison
Journal:  Stem Cell Res Ther       Date:  2017-06-05       Impact factor: 6.832

10.  Epiblast cell number and primary embryonic stem cell colony generation are increased by culture of cleavage stage embryos in insulin.

Authors:  Jared M Campbell; Michelle Lane; Ivan Vassiliev; Mark B Nottle
Journal:  J Reprod Dev       Date:  2012-11-21       Impact factor: 2.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.